The findings indicated a statistically significant correlation between the expression levels of RAF1 and the overall survival of AML patients, yielding a log-rank value of 0.0002 and a hazard ratio of 0.79 (with a confidence interval ranging from 0.7 to 0.9) (Fig. 2). This evidence concerns the gene RAF1 and acute myeloid leukemia.